126 related articles for article (PubMed ID: 9580606)
1. Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides.
Brenneman DE; Hauser J; Neale E; Rubinraut S; Fridkin M; Davidson A; Gozes I
J Pharmacol Exp Ther; 1998 May; 285(2):619-27. PubMed ID: 9580606
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats.
Kumral A; Yesilirmak DC; Sonmez U; Baskin H; Tugyan K; Yilmaz O; Genc S; Gokmen N; Genc K; Duman N; Ozkan H
Brain Res; 2006 Oct; 1115(1):169-78. PubMed ID: 16938277
[TBL] [Abstract][Full Text] [Related]
3. Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: immunological and biological specificity.
Gozes I; Davidson A; Gozes Y; Mascolo R; Barth R; Warren D; Hauser J; Brenneman DE
Brain Res Dev Brain Res; 1997 Apr; 99(2):167-75. PubMed ID: 9125470
[TBL] [Abstract][Full Text] [Related]
4. A femtomolar-acting neuroprotective peptide induces increased levels of heat shock protein 60 in rat cortical neurons: a potential neuroprotective mechanism.
Zamostiano R; Pinhasov A; Bassan M; Perl O; Steingart RA; Atlas R; Brenneman DE; Gozes I
Neurosci Lett; 1999 Apr; 264(1-3):9-12. PubMed ID: 10320001
[TBL] [Abstract][Full Text] [Related]
5. Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze.
Gozes I; Giladi E; Pinhasov A; Bardea A; Brenneman DE
J Pharmacol Exp Ther; 2000 Jun; 293(3):1091-8. PubMed ID: 10869414
[TBL] [Abstract][Full Text] [Related]
6. The peptides ADNF-9 and NAP increase survival and neurite outgrowth of rat retinal ganglion cells in vitro.
Lagrèze WA; Pielen A; Steingart R; Schlunck G; Hofmann HD; Gozes I; Kirsch M
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):933-8. PubMed ID: 15728550
[TBL] [Abstract][Full Text] [Related]
7. A femtomolar-acting neuroprotective peptide.
Brenneman DE; Gozes I
J Clin Invest; 1996 May; 97(10):2299-307. PubMed ID: 8636410
[TBL] [Abstract][Full Text] [Related]
8. VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress.
Steingart RA; Solomon B; Brenneman DE; Fridkin M; Gozes I
J Mol Neurosci; 2000 Dec; 15(3):137-45. PubMed ID: 11303778
[TBL] [Abstract][Full Text] [Related]
9. Activity-dependent neurotrophic factor-9 and NAP promote neurite outgrowth in rat hippocampal and cortical cultures.
Smith-Swintosky VL; Gozes I; Brenneman DE; D'Andrea MR; Plata-Salaman CR
J Mol Neurosci; 2005; 25(3):225-38. PubMed ID: 15800376
[TBL] [Abstract][Full Text] [Related]
10. Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against beta-amyloid toxicity.
Caraci F; Chisari M; Frasca G; Canonico PL; Battaglia A; Calafiore M; Battaglia G; Bosco P; Nicoletti F; Copani A; Sortino MA
Brain Res; 2005 Jun; 1047(1):30-7. PubMed ID: 15882840
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.
Offen D; Sherki Y; Melamed E; Fridkin M; Brenneman DE; Gozes I
Brain Res; 2000 Jan; 854(1-2):257-62. PubMed ID: 10784133
[TBL] [Abstract][Full Text] [Related]
12. Activity-dependent neurotrophic factor, ADNF, determines the structure characteristics of Colivelin, a fusion protein of ADNF9 and Humanin analog.
Arakawa T; Niikura T; Arisaka F; Kita Y
J Pept Sci; 2008 May; 14(5):631-6. PubMed ID: 17994638
[TBL] [Abstract][Full Text] [Related]
13. A new concept in the pharmacology of neuroprotection.
Gozes I; Brenneman DE
J Mol Neurosci; 2000; 14(1-2):61-8. PubMed ID: 10854037
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain.
Gressens P; Marret S; Hill JM; Brenneman DE; Gozes I; Fridkin M; Evrard P
J Clin Invest; 1997 Jul; 100(2):390-7. PubMed ID: 9218516
[TBL] [Abstract][Full Text] [Related]
15. Protective peptides derived from novel glial proteins.
Brenneman DE; Spong CY; Gozes I
Biochem Soc Trans; 2000; 28(4):452-5. PubMed ID: 10961938
[TBL] [Abstract][Full Text] [Related]
16. Activity-dependent neurotrophic factor-14 requires protein kinase C and mitogen-associated protein kinase kinase activation to protect the developing mouse brain against excitotoxicity.
Gressens P; Marret S; Bodénant C; Schwendimann L; Evrard P
J Mol Neurosci; 1999; 13(1-2):199-210. PubMed ID: 10691306
[TBL] [Abstract][Full Text] [Related]
17. Brain deficits associated with fetal alcohol exposure may be protected, in part, by peptides derived from activity-dependent neurotrophic factor and activity-dependent neuroprotective protein.
Sari Y; Gozes I
Brain Res Rev; 2006 Aug; 52(1):107-18. PubMed ID: 16488478
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures.
McDonald JW; Goldberg MP; Gwag BJ; Chi SI; Choi DW
Ann Neurol; 1996 Nov; 40(5):750-8. PubMed ID: 8957016
[TBL] [Abstract][Full Text] [Related]
19. VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting neuroprotective peptide.
Brenneman DE; Glazner G; Hill JM; Hauser J; Davidson A; Gozes I
Ann N Y Acad Sci; 1998 Dec; 865():207-12. PubMed ID: 9928014
[TBL] [Abstract][Full Text] [Related]
20. Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing.
Marcade M; Bourdin J; Loiseau N; Peillon H; Rayer A; Drouin D; Schweighoffer F; Désiré L
J Neurochem; 2008 Jul; 106(1):392-404. PubMed ID: 18397369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
